标题
Research needs in breast cancer
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages mdw571
出版商
Oxford University Press (OUP)
发表日期
2016-11-02
DOI
10.1093/annonc/mdw571
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SWOG S1007: A phase III, randomized clinical trial of standard adjuvant endocrine therapy with or without chemotherapy in patients with one to three positive nodes, hormone receptor (HR)-positive, and HER2-negative breast cancer with recurrence score (RS) of 25 or less.
- (2017) A. M. Gonzalez-Angulo et al. JOURNAL OF CLINICAL ONCOLOGY
- The global decrease in cancer mortality: trends and disparities
- (2016) D. Hashim et al. ANNALS OF ONCOLOGY
- Defining research priorities without biases: what is the optimal process?
- (2016) S. Dogan et al. ANNALS OF ONCOLOGY
- An e-health strategy to facilitate care of breast cancer survivors: A pilot study
- (2016) Siaw Sze Tiong et al. Asia-Pacific Journal of Clinical Oncology
- Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data
- (2016) Neelima Vidula et al. Clinical Breast Cancer
- New Strategies in Breast Cancer: Immunotherapy
- (2016) L. Pusztai et al. CLINICAL CANCER RESEARCH
- Treatment strategies for advanced hormone receptor-positive and human epidermal growth factor 2-negative breast cancer: the role of treatment order
- (2016) Edith A. Perez DRUG RESISTANCE UPDATES
- A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
- (2016) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment
- (2016) Oleg Gluz et al. JOURNAL OF CLINICAL ONCOLOGY
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
- (2016) Carolyn D. Runowicz et al. JOURNAL OF CLINICAL ONCOLOGY
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011
- (2016) Alexandra Thomas et al. JAMA Surgery
- Genetics of breast cancer: a topic in evolution
- (2015) S. Shiovitz et al. ANNALS OF ONCOLOGY
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- PARP inhibitors in the management of breast cancer: current data and future prospects
- (2015) Luca Livraghi et al. BMC Medicine
- Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015
- (2015) Dimitrios Zardavas et al. BREAST
- Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer
- (2015) Katrin Almstedt et al. Breast Care
- Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review
- (2015) Neha A. Deshpande et al. CANCER
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- International Variation in Female Breast Cancer Incidence and Mortality Rates
- (2015) C. E. DeSantis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Proteomics discovery of radioresistant cancer biomarkers for radiotherapy
- (2015) Lei Chang et al. CANCER LETTERS
- Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
- (2015) C. Criscitiello et al. EJSO
- BREATH: Web-Based Self-Management for Psychological Adjustment After Primary Breast Cancer—Results of a Multicenter Randomized Controlled Trial
- (2015) Sanne W. van den Berg et al. JOURNAL OF CLINICAL ONCOLOGY
- Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?
- (2015) Cindy Railton et al. Journal of the National Comprehensive Cancer Network
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- (2015) Sara A Hurvitz et al. LANCET ONCOLOGY
- Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014
- (2015) Sandra R Distelhorst et al. LANCET ONCOLOGY
- A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
- (2015) Bartlomiej Waclaw et al. NATURE
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Clinical management of breast cancer heterogeneity
- (2015) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Breast cancer therapy-associated cardiovascular disease
- (2015) Timothy M. Zagar et al. Nature Reviews Clinical Oncology
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
- (2015) Sara M. Tolaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
- (2014) F. Cardoso et al. ANNALS OF ONCOLOGY
- First international consensus guidelines for breast cancer in young women (BCY1)
- (2014) Ann H. Partridge et al. BREAST
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
- (2014) Lydia E. Pace et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Naren Ramakrishna et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2014) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast conservation: Is the survival better for mastectomy?
- (2014) E. Shelley Hwang JOURNAL OF SURGICAL ONCOLOGY
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
- (2014) Olivia Pagani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
- (2014) Vanessa Almendro et al. Cell Reports
- Meta-Analysis to Determine if Surgical Resection of the Primary Tumour in the Setting of Stage IV Breast Cancer Impacts on Survival
- (2013) Elly Harris et al. ANNALS OF SURGICAL ONCOLOGY
- Biomarkers of Radiation Exposure: Can They Predict Normal Tissue Radiosensitivity?
- (2013) M.L.K. Chua et al. CLINICAL ONCOLOGY
- Designing Transformative Clinical Trials in the Cancer Genome Era
- (2013) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
- (2013) Aron Goldhirsch et al. LANCET
- 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
- (2013) Xavier Pivot et al. LANCET ONCOLOGY
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- (2013) Daniel Hofmann et al. Trials
- 1st International consensus guidelines for advanced breast cancer (ABC 1)
- (2012) F. Cardoso et al. BREAST
- Current approaches and future directions in the treatment of HER2-positive breast cancer
- (2012) Sara A. Hurvitz et al. CANCER TREATMENT REVIEWS
- Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
- (2012) Hatem A. Azim et al. CLINICAL CANCER RESEARCH
- Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
- (2012) K. Cocks et al. EUROPEAN JOURNAL OF CANCER
- A systematic review of quality of life instruments in long-term breast cancer survivors
- (2012) Ishveen Chopra et al. Health and Quality of Life Outcomes
- A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017
- (2012) T. Shien et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation
- (2012) Jetske Ruiterkamp et al. BMC Surgery
- Long-term toxic effects of adjuvant chemotherapy in breast cancer
- (2011) H. A. Azim et al. ANNALS OF ONCOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
- (2011) Benjamin O Anderson et al. LANCET ONCOLOGY
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
- (2010) Kim Cocks et al. JOURNAL OF CLINICAL ONCOLOGY
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
- (2010) O. Pagani et al. JNCI-Journal of the National Cancer Institute
- Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
- (2009) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
- (2009) Hanna Fredholm et al. PLoS One
- Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials
- (2008) Kim Cocks et al. EUROPEAN JOURNAL OF CANCER
- Cancer survival in five continents: a worldwide population-based study (CONCORD)
- (2008) Michel P Coleman et al. LANCET ONCOLOGY
- The emerging landscape of breast cancer susceptibility
- (2007) Michael R Stratton et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now